Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide
- PMID: 21480671
- PMCID: PMC3711080
- DOI: 10.1021/bc2000947
Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide
Abstract
The antagonistic Ac-TZ14011 peptide, which binds to the chemokine receptor 4, has been labeled with a multifunctional single attachment point reagent that contains a DTPA chelate and a fluorescent dye with Cy5.5 spectral properties. Flow cytometry and confocal microscopy showed that the bimodal labeled peptide gave a specific receptor binding that is similar to monofunctionalized peptide derivatives. Therefore, the newly developed bimodal peptide derivative can be used in multimodal imaging applications.
Figures




References
-
- Furusato B, Mohamed A, Uhlen M, Rhim JS. CXCR4 and cancer. Pathol. Int. 2010;60:497–505. - PubMed
-
- Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer. Res. 2010;16:2927–2931. - PubMed
-
- Salvucci O, Bouchard A, Baccarelli A, Deschenes J, Sauter G, Simon R, Bianchi R, Basik M. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res. Treat. 2006;97:275–283. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources